Search Results Search Sort by RelevanceMost Recent Medicine and Society Jul 2021 Invisibility of “Gender Dysphoria” Nicolle K. Strand, JD, MBE and Nora L. Jones, PhD Fostering transgender patients’ sense of agency should be a clinical and ethical priority. AMA J Ethics. 2021;23(7):E557-562. doi: 10.1001/amajethics.2021.557. Policy Forum Feb 2016 Regulations’ Impact on Donor and Recipient Selection for Liver Transplantation: How Should Outcomes be Measured and MELD Exception Scores be Considered? Joel T. Adler, MD, MPH and David A. Axelrod, MD, MBA Standards for posttransplant graft/survival rates do not reward transplant centers for performing riskier transplants to increase population benefit. AMA J Ethics. 2016;18(2):133-142. doi: 10.1001/journalofethics.2017.18.2.pfor1-1602. Policy Forum Jan 2008 Wellness Programs: Legality, Fairness, and Relevance Laura D. Hermer, JD, LLM Wellness programs and health plan incentives may not be effective means for combating addiction and other lifestyle-related conditions. Virtual Mentor. 2008;10(1):45-48. doi: 10.1001/virtualmentor.2008.10.1.pfor1-0801. Policy Forum Sep 2005 Presumed vs Expressed Consent in the US and Internationally Sheldon Zink, PhD, Rachel Zeehandelaar, and Stacey Wertlieb, MBe The benefits of the international presumed-consent policy are presented as a solution to the United States' current shortage of organs available for transplantation. Virtual Mentor. 2005;7(9):610-614. doi: 10.1001/virtualmentor.2005.7.9.pfor2-0509. Policy Forum Nov 2016 Affirmative and Responsible Health Care for People with Nonconforming Gender Identities and Expressions Kristen L. Eckstrand, MD, PhD, Henry Ng, MD, MPH, and Jennifer Potter, MD Physicians should extend gender-affirming treatment to gender-nonconforming people, who experience discrimination and health disparities. AMA J Ethics. 2016;18(11):1107-1118. doi: 10.1001/journalofethics.2016.18.11.pfor1-1611. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2
Medicine and Society Jul 2021 Invisibility of “Gender Dysphoria” Nicolle K. Strand, JD, MBE and Nora L. Jones, PhD Fostering transgender patients’ sense of agency should be a clinical and ethical priority. AMA J Ethics. 2021;23(7):E557-562. doi: 10.1001/amajethics.2021.557.
Policy Forum Feb 2016 Regulations’ Impact on Donor and Recipient Selection for Liver Transplantation: How Should Outcomes be Measured and MELD Exception Scores be Considered? Joel T. Adler, MD, MPH and David A. Axelrod, MD, MBA Standards for posttransplant graft/survival rates do not reward transplant centers for performing riskier transplants to increase population benefit. AMA J Ethics. 2016;18(2):133-142. doi: 10.1001/journalofethics.2017.18.2.pfor1-1602.
Policy Forum Jan 2008 Wellness Programs: Legality, Fairness, and Relevance Laura D. Hermer, JD, LLM Wellness programs and health plan incentives may not be effective means for combating addiction and other lifestyle-related conditions. Virtual Mentor. 2008;10(1):45-48. doi: 10.1001/virtualmentor.2008.10.1.pfor1-0801.
Policy Forum Sep 2005 Presumed vs Expressed Consent in the US and Internationally Sheldon Zink, PhD, Rachel Zeehandelaar, and Stacey Wertlieb, MBe The benefits of the international presumed-consent policy are presented as a solution to the United States' current shortage of organs available for transplantation. Virtual Mentor. 2005;7(9):610-614. doi: 10.1001/virtualmentor.2005.7.9.pfor2-0509.
Policy Forum Nov 2016 Affirmative and Responsible Health Care for People with Nonconforming Gender Identities and Expressions Kristen L. Eckstrand, MD, PhD, Henry Ng, MD, MPH, and Jennifer Potter, MD Physicians should extend gender-affirming treatment to gender-nonconforming people, who experience discrimination and health disparities. AMA J Ethics. 2016;18(11):1107-1118. doi: 10.1001/journalofethics.2016.18.11.pfor1-1611.